Re:benefit announced that it has received 1,167,000 in a round of funding on November 11, 2022. The transaction included participation from ImVentures II, a fund managed by ImPulse I AD for proceeds of 307,000, New Vision 3 Venture Capital Fund and Vitosha Venture Partners Ltd. and new investor Impetus Capital, LLC, Investment Arm
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 BGN | +1.27% | +3.23% | +26.98% |
29/04 | ImPulse I AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | ImPulse I AD Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+26.98% | 5.26M | |
+22.33% | 83.71B | |
+62.69% | 18.29B | |
+9.84% | 17.75B | |
+11.77% | 15.27B | |
-2.32% | 12.7B | |
+2.46% | 11.49B | |
+3.37% | 10.72B | |
-2.34% | 9.84B | |
+29.27% | 9.78B |
- Stock Market
- Equities
- IMP Stock
- News Impulse I Ad
- Re: benefit announced that it has received €1.167 million in funding from ImPulse I AD, Vitosha Venture Partners Ltd., New Vision 3 Venture Capital Fund, Impetus Capital, LLC, Investment Arm